D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
John Wiley & Sons Class A
WLY
$2.61B
| $3.95M | 0.01% |
105,415
-38,592
| -27% | -$1.62M |
|
1577
CALL
AstraZeneca
AZN
$263B
| $3.94M | 0.01% |
44,100
| – | – |
|
1578
PUT
ResMed
RMD
$29.4B
| $3.93M | 0.01% |
26,700
+7,700
| +41% | +$1.23M |
|
1579
Buckle
BKE
$2.24B
| $3.93M | 0.01% |
286,652
+22,504
| +9% | +$507K |
|
|
KSU
1580
CALL
DELISTED
Kansas City Southern
KSU
| $3.93M | 0.01% |
30,900
+5,500
| +22% | +$839K |
|
1581
CALL
American Express
AXP
$228B
| $3.92M | 0.01% |
45,800
-18,800
| -29% | -$2.19M |
|
1582
Fortune Brands Innovations
FBIN
$6.16B
| $3.92M | 0.01% |
106,017
-277,473
| -72% | -$14.7M |
|
1583
IDT Corp
IDT
$1.64B
| $3.92M | 0.01% |
722,421
-64,755
| -8% | -$463K |
|
1584
Huron Consulting
HURN
$1.86B
| $3.91M | 0.01% |
86,265
+50,514
| +141% | +$3.05M |
|
1585
Orthofix Medical
OFIX
$475M
| $3.89M | 0.01% |
138,868
+1,421
| +1% | +$55K |
|
|
FLOW
1586
DELISTED
SPX FLOW, Inc.
FLOW
| $3.89M | 0.01% |
136,835
-80,876
| -37% | -$3.08M |
|
|
WRI
1587
DELISTED
Weingarten Realty Investors
WRI
| $3.89M | 0.01% |
269,394
+252,588
| +1,503% | +$6.67M |
|
1588
Hewlett Packard
HPE
$62.7B
| $3.87M | 0.01% |
+398,443
| New | +$5.22M |
|
1589
GATX Corp
GATX
$6.49B
| $3.85M | 0.01% |
61,592
-58,968
| -49% | -$4.29M |
|
1590
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $3.85M | 0.01% |
226,074
+42,507
| +23% | +$1.25M |
|
|
DAY
1591
DELISTED
Dayforce
DAY
| $3.85M | 0.01% |
76,889
+29,846
| +63% | +$1.98M |
|
|
AIMC
1592
DELISTED
Altra Industrial Motion Corp
AIMC
| $3.85M | 0.01% |
219,971
-3,485
| -2% | -$104K |
|
1593
Ardelyx
ARDX
$1.27B
| $3.85M | 0.01% |
676,402
-265,147
| -28% | -$1.8M |
|
1594
Applied Optoelectronics
AAOI
$7.85B
| $3.83M | 0.01% |
505,129
+60,846
| +14% | +$642K |
|
|
PRSU
1595
Pursuit Attractions and Hospitality Inc
PRSU
$1.44B
| $3.83M | 0.01% |
180,439
+175,459
| +3,523% | +$9.04M |
|
1596
PUT
Ulta Beauty
ULTA
$20.5B
| $3.83M | 0.01% |
21,800
-25,200
| -54% | -$6.28M |
|
1597
CALL
NewMarket
NEU
$7.25B
| $3.83M | 0.01% |
10,000
| – | – |
|
|
CADE
1598
DELISTED
Cadence Bank
CADE
| $3.83M | 0.01% |
202,123
+60,764
| +43% | +$1.61M |
|
1599
CarGurus
CARG
$3.16B
| $3.81M | 0.01% |
201,240
+94,042
| +88% | +$2.69M |
|
1600
Core Laboratories
CLB
$523M
| $3.81M | 0.01% |
368,167
+333,080
| +949% | +$9.32M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.